Monitoring of 29 weight loss compounds in foods and dietary supplements by LC-MS/MS
Authors:
- Hyung Joo KimHyung Joo Kim
- Ji Hyun LeeJLJi Hyun Lee
- Hyoung Joon ParkHPHyoung Joon Park
- So-Hyun ChoSCSo-Hyun Cho
- Sooyeul ChoSCSooyeul Cho
- Woo Seong KimWKWoo Seong Kim
- 26 March 2014
- journal article
- research article
- Published by Taylor & Francis in Food Additives & Contaminants: Part A
- Vol. 31 (5) , 777-783
Abstract
Because of the rapid growth in dietary supplement availability and public concern for weight control, the investigation of foods and various dietary supplements illegally adulterated with weight loss compounds has become increasingly important. A total of 29 weight loss compounds, including sennoside, sibutramine, ephedrine and their analogues, found to be adulterated in foods and dietary supplements were simultaneously examined by LC-MS/MS. The 188 samples were collected between 2009 and 2012 in South Korea, and method validation was performed to determine the adulterants to the weight loss compounds. LODs, LOQs and linearity ranged from 0.03 to 7.5 ng ml⁻¹, from 0.08 to 30.00 ng ml⁻¹, and from 0.990 to 0.999, respectively. The results showed that nine weight loss compounds, namely bisacodyl, desmethylsibutramine, didesmethylsibutramine, ephedrine, fluoxetine, pseudoephedrine, sennoside A, sennoside B and sibutramine, were detected in 62 of all collected samples and were found in order of frequency as follows: sibutramine, 25.7%; sennoside A, 22.9%; sennoside B, 20.0%; fluoxetine, 8.6%; desmethylsibutramine, 7.1%; bisacodyl, ephedrine, and pseudoephedrine, 4.3%; and didesmethylsibutramine, 2.9%. Sibutramine, which was the most frequently found adulterant, ranged in levels from 0.03 to 132.40 mg g⁻¹ (2010), from 0.88 to 76.2 mg g⁻¹ (2011), and from 0.07 to 0.24 mg g⁻¹ (2012). Although the concentrations of most compounds ranged widely, some compounds such as bisacodyl and fluoxetine were found at high concentrations in several samples.Keywords
This publication has 16 references indexed in Scilit:
- Qualitative screening for adulterants in weight-loss supplements by ion mobility spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2012
- Quantification of sibutramine and its two metabolites in human plasma by LC–ESI-MS/MS and its application in a bioequivalence studyJournal of Pharmaceutical Analysis, 2012
- A GC–EI-MS-MS Method for Simultaneous Determination of Seven Adulterants in Slimming Functional FoodsJournal of Chromatographic Science, 2012
- Comparative determination of sibutramine as an adulterant in natural slimming products by HPLC and HPTLC densitometryJournal of Pharmaceutical and Biomedical Analysis, 2012
- Presence of synthetic pharmaceuticals as adulterants in slimming phytotherapeutic formulations and their analytical determinationForensic Science International, 2011
- Using a portable ion mobility spectrometer to screen dietary supplements for sibutramineJournal of Pharmaceutical and Biomedical Analysis, 2010
- A rapid and reliable UPLC‐MS/MS method for the identification and quantification of fourteen synthetic anti‐diabetic drugs in adulterated Chinese proprietary medicines and dietary supplementsBiomedical Chromatography, 2010
- Simultaneous determination of anti‐diabetes/anti‐obesity drugs by LC/PDA, and targeted analysis of sibutramine analog in dietary supplements by LC/MS/MSBiomedical Chromatography, 2009
- Simultaneous Determination of Sibutramine and N-Di-desmethylsibutramine in Dietary Supplements for Weight Control by HPLC--ESI-MSJournal of Chromatographic Science, 2008
- Liquid chromatography/electrospray ionization tandem mass spectrometry validated method for the simultaneous quantification of sibutramine and its primary and secondary amine metabolites in human plasma and its application to a bioequivalence studyRapid Communications in Mass Spectrometry, 2006